June 2013

Rx&D Report Shows 34% Under Report Rate of Innovation Investment By Government Agencies

report by Rx&D, the Canadian association of pharmaceutical companies, confirms an ongoing trend of under-reporting of pharmaceutical innovation investment by government bodies. The report, released in May, shows a consistent…
Read More

Should Pharmaceutical Sales Professionals Educate Doctors About Drug Risks?

A recent study of 255 physicians in Canada, the United States and France highlights the important impact of pharmaceutical sales on doctors’ decisions and physicians’ reliance on sales representatives’ willingness…
Read More

Generics in Ontario

Last week we covered a generic drug pricing deal that will affect most of Canada. This week we’re coming back to Ontario to take a closer look at the local…
Read More